Skip to content

Acute Effects of TCIG vs ECIG in PLWH

Acute Impact of Switching From Tobacco Cigarettes to E-Cigarettes in People Living With HIV

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04568395
Enrollment
37
Registered
2020-09-29
Start date
2020-10-01
Completion date
2023-05-08
Last updated
2023-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E Cigarette Use, HIV I Infection, Inflammation, Nicotine Use Disorder, Oxidative Stress, Qt Interval, Variation in, Smoking, Tobacco Smoking, Vaping

Brief summary

Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization and inflammation/oxidative stress.

Detailed description

On separate days, participants will undergo 3 different exposures: an acute e-cigarette exposure, an acute tobacco cigarette exposure, and a sham (empty e-cigarette) control . Before and after the acute exposure, participants will have blood drawn for inflammation/oxidative stress markers and undergo a 5-minute ECG recording.

Interventions

OTHERTCIG

Use a TCIG

OTHERECIG

Use an ECIG

OTHERsham control

Use a sham control (empty ECIG)

Sponsors

Tobacco Related Disease Research Program
CollaboratorOTHER
University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

single (outcomes assessor) code

Intervention model description

Crossover with 1 week washout

Eligibility

Sex/Gender
ALL
Age
21 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

Chronic (\> 1year) TCIG smoker HIV positive Stable ART Viral count non-detectable CD4 \>500

Exclusion criteria

Known major illness (heart disease, diabetes, lung or liver disease) Daily recreational drug use, including cannabis \>2 alcoholic drinks per day Obesity (\>30 kg/m2) Recent (\<3 months) infection

Design outcomes

Primary

MeasureTime frameDescription
TpeChange in Tpe 5 minutes after cigarette useinterval indicative of ventricular repolarization measured on ECG
Tpe/QTChange in Tpe/QT after cigarette useinterval indicative of ventricular repolarization measured on ECG
Tpe/QTcChange in Tpe/QTc after cigarette useinterval indicative of ventricular repolarization measured on ECG
Total Cellular Reactive Oxygen Stresswithin 4 hours of cigarette usetotal cellular oxidative stress measured by flow cytometry

Secondary

MeasureTime frameDescription
QTChange in QT after cigarette useinterval indicative of ventricular repolarization measured on ECG
QTcChange in QTc after cigarette useinterval indicative of ventricular repolarization measured on ECG

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026